MNX Market Network Exchange
Commercial intelligence · New York
Menu
$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

Lobbying client · New York

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA)

8 lobbyists engaged · 30 registrations

See every filing in the registry →

Who it has engaged

LobbyistLevelOnCompensationTerm
ALBANY STRATEGIC ADVISORS, LLCStateAnticipate the $5,000 threshold will be exceeded$7500 · MonthlyMar 2026 – Dec 2026
DICKINSON & AVELLA, PLLCStateAnticipate the $5,000 threshold will be exceeded$15833 · MonthlyJan 2025 – Dec 2025
DICKINSON & AVELLA, PLLCStateAnticipate the $5,000 threshold will be exceeded$15833 · MonthlyJan 2023 – Dec 2023
DICKINSON & AVELLA, PLLC.StateAnticipate the $5,000 threshold will be exceeded$15833 · MonthlyJan 2023 – Dec 2023
DISTINCTIVE PUBLIC AFFAIRS, LLCStateAnticipate the $5,000 threshold will be exceeded$11667 · MonthlyJan 2025 – Dec 2025
DISTINCTIVE PUBLIC AFFAIRS, LLCStateAnticipate the $5,000 threshold will be exceeded$11667 · MonthlyJan 2024 – Dec 2024
J STRATEGIES INC.StateAnticipate the $5,000 threshold will be exceeded$20833 · MonthlyJan 2025 – Dec 2025
J STRATEGIES INC.StateAnticipate the $5,000 threshold will be exceeded$20833 · MonthlyJan 2023 – Dec 2023
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA)StateAnticipate the $5,000 threshold will be exceeded$$5,000-6,000 · RangeJan 2025 – Dec 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA)StateAnticipate the $5,000 threshold will be exceeded$$5,000-6,000 · RangeJan 2023 – Dec 2024
THE WRIGHT GROUP NY, INC.StateAnticipate the $5,000 threshold will be exceeded$6667 · MonthlyJan 2023 – Mar 2023
TRESS CAPITOL ADVISORS LLCStateAnticipate the $5,000 threshold will be exceeded$300000 · AnuallyJan 2025 – Dec 2025
TRESS CAPITOL ADVISORS LLCStateAnticipate the $5,000 threshold will be exceeded$275000 · AnuallyJan 2023 – Dec 2023

Public record from the NY Ethics Commission (COELIG) and the NYC City Clerk. We publish it because it makes the influence landscape legible, not to imply that access can be bought.

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA): lobbying representation · MNX